Vertex cystic fibrosis triple combo therapy succeeds in important trials

Vertex Pharmaceuticals Inc on Wednesday said its triple-combination treatment for cystic fibrosis led to significant lung function improvement in two late-stage studies, paving the way for a therapy that could eventually address 90 percent of people with the life-shortening genetic condition.

from Reuters: Health https://ift.tt/2UoyeOK
via IFTTT

• Tweet
• Share
• Share
• Share
• Share